BioSpectrum Asia: Australia - A thriving lifescience hub with a global reach

In an interview with BioSpectrum Asia, Novotech CEO Dr John Moller provides his thoughts on the state of Australia's medical technologies, biotechnology and pharmaceutical (MTP) sector.

BioSpectrum Asia: Australia - A thriving lifescience hub with a global reach
20 October 2017, by Aishwarya Venkatesh

Other relevant content

September 24, 2023 News

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Read more

July 12, 2023 News

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

Read more

July 10, 2023 News

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA…

Read more

June 21, 2023 News

Novotech Selected for Biotech CRO Leadership Award 2023

Read more

May 29, 2023 News

Novotech Sponsors BIO 2023 APAC Summit and the Endpoints Panel on Forging Biotech Ties with China

Read more

May 26, 2023 News

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

Read more

May 5, 2023 News

Industry Survey Identifies Successful Biotech Clinical Trial Strategies

Read more

April 13, 2023 News

Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer…

Read more

March 31, 2023 News

GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways

Read more

November 29, 2021 News

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA…

Primary Biliary Cholangitis – Global Clinical Trial Landscape (2023)

Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

Clinical trials in China: unlocking the potential of advanced therapies

Endpoints at BIO 2023: Forging new biotech ties with China

Phase I study helps company secure second indication for lead product with Healthy volunteer study…

Rare Disease Clinical Trials: Unveiling Insights and Charting Progress

Infectious Diseases – Global Clinical Trial Landscape (2018-2023)

Covid-19 Notice important updates

Find content relevant to:

OCT Southern California

The Chinese Bioscience Association (CBA) West Annual Conference

Medical and Regulatory Consulting

Patient Recruitment and Site Selection

Early Phase Trials in Australia

Clinical Operations and Project Management

Site Management Organization (SMO)

Biometrics and Data Management

Virtual Clinical Trials

Real world data

Laboratory Services

FLEX

Oncology CRO services

Pharmacometric Services

Drug Development Consulting

GMO Solutions

Liver Disease CRO services

Infectious diseases and Vaccines CRO services

Orphan and rare disease CRO services

Clinical and Regulatory Strategy

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house Novotech Drug Development Consulting team.

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

BioSpectrum Asia: Australia - A thriving lifescience hub with a global reach

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA…

Primary Biliary Cholangitis – Global Clinical Trial Landscape (2023)

Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

Clinical trials in China: unlocking the potential of advanced therapies

Endpoints at BIO 2023: Forging new biotech ties with China

Phase I study helps company secure second indication for lead product with Healthy volunteer study…

Rare Disease Clinical Trials: Unveiling Insights and Charting Progress

Infectious Diseases – Global Clinical Trial Landscape (2018-2023)

Covid-19 Notice important updates

Find content relevant to:

OCT Southern California

The Chinese Bioscience Association (CBA) West Annual Conference

Medical and Regulatory Consulting

Patient Recruitment and Site Selection

Early Phase Trials in Australia

Clinical Operations and Project Management

Site Management Organization (SMO)

Biometrics and Data Management

Virtual Clinical Trials

Real world data

Laboratory Services

FLEX

Oncology CRO services

Pharmacometric Services

Drug Development Consulting

GMO Solutions

Liver Disease CRO services

Infectious diseases and Vaccines CRO services

Orphan and rare disease CRO services

Clinical and Regulatory Strategy

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house Novotech Drug Development Consulting team.

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

Other relevant content

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA…

Novotech Selected for Biotech CRO Leadership Award 2023

Novotech Sponsors BIO 2023 APAC Summit and the Endpoints Panel on Forging Biotech Ties with China

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

Industry Survey Identifies Successful Biotech Clinical Trial Strategies

Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer…

GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways

Congratulations to the Novotech Seoul Korea team

Clinical Leader Announces Novotech a 2021 CRO Leadership Award Winner

Novotech named as one the Best Companies to Work for in Asia 2021